Complications, Indication and Tolerance of Foam Sclerotherapy in Varicose Vein Management Done in A Tertiary Care Centre in South India

Keywords: Varicose Vein, Sclerotherapy, Sclerosant


INTRODUCTION: Foam sclerotherapy is used for treating varicose veins in our institution for patients who are not willing for surgery, debilitated patients, recurrent ulcers, cosmetic & in SFV (Sapheno Femoral Vein) <6 mm size.
AIM: The aim of this study was to find and assess the rate and pattern of post–sclerotherapy complications in our institution compared with international standards.
MATERIALS AND METHOD: The present study was retrospective in nature and case records of patients who underwent foam sclerotherapy [2009-2013, lower limb-Ultrasound (USG) guided and blind] in our hospital [10% Sodiumtetradecylsulfate (STS), Tessari technique] were assessed to look for indication, tolerance to the procedure and immediate outcomes. A pre-tested and pre-validated questionnaire was used and physical examination were done to assess post-procedural complications. Statistical significance was p< 0.05.
RESULTS: Among 112 patients, 62.5 % were aged >50 years and 69% were males. It was observed that 22% had indication as recurrence; 43% had mild pain during procedure and 36.6% developed post-foam sclerotherapy complications. 47.6% of patients whose age were <50 years had CEAP(Clinical Etiological Anatomical Pathological) criteria C2(p=0.007). 48.8% with complications had multiple criteria(p=0.012) and 57.7% C2 had least complication (p=0.000). Cosmetic indication showed least tolerance. Use of 10% STS was found to have lesser complication rate (36%), compared to study which had 76% success with STS 3% and complication-64%.
CONCLUSION: Foam sclerotherapy is less invasive and its efficacy could be improved by performing under USG guidance, selection of sclerosant, appropriate candidate (age>50 years, multiple CEAP criteria, without pre-existing co-morbidities).


Download data is not yet available.

Author Biographies

Punitha Thetrarauv Oli

MBBS, MS (Fellow in Vascular Surgery), Dr. Somervell Memorial CSI Medical College, Karakonam, Trivandrum

Mahitha MC

MBBS, Dr. Somervell Memorial CSI Medical College, Karakonam, Trivandrum


Solomon AC, Maurya DK. Ultrasound guided foam sclerotherapy for varicose veins using two needle technique – A case series. Indian J Surg. 2010;72:249-51.

Bailey, Love. Short practice of surgery. (26th ed.) London: Hodder Arnold; 1991.

Callam MJ. Epidemiology of varicose veins. Br J Surg. 1994 Feb;81(2):167-73.

Eklof B, Rutherford RB, Bergan JJ. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;50(6): 1248-52.

Malhotra SL. An epidemiological study of varicose veins in Indian railroad workers from the south and north India with special reference to causation and prevention of varicose veins. Int J Epid. 2011;1(2):177-83.

Tan VKM, Tan SG. Technique and early results of ultrasound-guided foam sclerotherapy of the long saphenous vein for treatment of varicose veins. Singapore Med J. 2009;50(3): 284-7.

Robert L. Wrothington-Kirsch. Injection Sclerotherapy. Semin Intervent Radiol. 2005;22(3):209-17.

Labas P, Ohradka B, Cambal M, Reis R, Fillo J. Long term results of compression sclerotherapy. Bratisl Lek Listy. 2003;104(2):78-81.

Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001 Jan;27(1):58-60.

Subbarao NT, Aradhya SS, Veerabhadrappa NH. Sclerotherapy in the management of varicose veins and its dermatological complications. Indian J Dermatol Venereol Leprol 2013; 79:383-8.

Fun SK. Varicose veins of the lower limbs: A study of aetiology and symptomatology. Hong Kong Pract. 1988;10:3319-26.

Kanter A, Thibault P. Saphenofemoral junction incompetence treated by ultrasound-guided sclerotherapy, Dermatol Surg. 1996. 22: 48-652.

Padbury A, Benveniste GL. Foam Echosclerotherapy of the small saphenous vein. Australian and New Zealand Journal of Phlebology. 2004;8:5-8.

Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004; 30 :1386-1390

Michaels JA, Campbell WB, Brazier JE. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess. 2006;10(13): 1-196.

Tisi PV, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev. 2006;(4):CD001732.

Breu FX, Guggenbichler S. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany. Dermatol Surg. 2004;30(5):709-17; discussion 717.

DOI: 10.26440/IHRJ/0410.01379
Published: 2021-01-18
How to Cite
Punitha Thetrarauv Oli, Mahitha MC. Complications, Indication and Tolerance of Foam Sclerotherapy in Varicose Vein Management Done in A Tertiary Care Centre in South India. IHRJ [Internet]. 2021Jan.18 [cited 2023Nov.30];4(10):OR7-OR14. Available from: